Live, Attenuated, Tetravalent Butantan–Dengue Vaccine in Children and Adults
New England Journal of Medicine · 2024-02 · 390 (5) · 397-408
DOI: 10.1056/nejmoa2301790 ↗Kurz gefasst
Klinische Studie (Phase III) in der Zeitschrift New England Journal of Medicine, 2024-02. Verfasst von Esper G Kallás und 34 weiteren Autor:innen. Beteiligte Einrichtung: From Instituto Butantan (E.G.K., M.A.T.C., J.A.M., E.G.P., P.E.B., J.C.V.T., V.I., R.P., D.T.C., J.K., A.R.P., F.C.B.), Hospital das Clínicas da Facu…. Hauptthemen laut MEDLINE: Dengue, Dengue Vaccines, Dengue Virus, Vaccines, Attenuated. Die Arbeit wurde bisher 219-mal zitiert (Crossref) und nennt 40 Literaturangaben. Gefördert von: Instituto Butantan, Merck Sharp and Dohme, Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc., Rahway, NJ, USA.
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- From Instituto Butantan (E.G.K., M.A.T.C., J.A.M., E.G.P., P.E.B., J.C.V.T., V.I., R.P., D.T.C., J.K., A.R.P., F.C.B.), Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo (E.G.K.), Departamento…
ORCID-Profile: Mauricio L Nogueira
Förderung
- Instituto Butantan
- Merck Sharp and Dohme
- Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc., Rahway, NJ, USA
Zitieren
APA
Kallás, E. G., Cintra, M. A. T., Moreira, J. A., Patiño, E. G., Braga, P. E., Tenório, J. C. V., Infante, V., Palacios, R., de Lacerda, M. V. G., Batista Pereira, D., da Fonseca, A. J., Gurgel, R. Q., Coelho, I. C., Fontes, C. J. F., Marques, E. T. A., Romero, G. A. S., Teixeira, M. M., Siqueira, A. M., Barral, A. M. P., …, & Nogueira, M. L. (2024). Live, Attenuated, Tetravalent Butantan–Dengue Vaccine in Children and Adults. New England Journal of Medicine, 390(5), 397-408. https://doi.org/10.1056/nejmoa2301790
Vancouver
Kallás EG, Cintra MAT, Moreira JA, Patiño EG, Braga PE, Tenório JCV, et al. Live, Attenuated, Tetravalent Butantan–Dengue Vaccine in Children and Adults. New England Journal of Medicine. 2024;390(5):397-408. doi:10.1056/nejmoa2301790
BibTeX
@article{Kalls2024,
author = {Kallás, Esper G and Cintra, Monica A T and Moreira, José A and Patiño, Elizabeth G and Braga, Patricia Emilia and Tenório, Juliana C V and Infante, Vanessa and Palacios, Ricardo and de Lacerda, Marcus Vínicius Guimarães and Batista Pereira, Dhelio and da Fonseca, Allex Jardim and Gurgel, Ricardo Queiroz and Coelho, Ivo Castelo-Branco and Fontes, Cor Jesus Fernandes and Marques, Ernesto T A and Romero, Gustavo Adolfo Sierra and Teixeira, Mauro Martins and Siqueira, André M and Barral, Aldina Maria Prado and Boaventura, Viviane Sampaio and Ramos, Fabiano and Elias Júnior, Erivaldo and Cassio de Moraes, José and Covas, Dimas T and Kalil, Jorge and Precioso, Alexander Roberto and Whitehead, Stephen S and Esteves-Jaramillo, Alejandra and Shekar, Tulin and Lee, Jung-Jin and Macey, Julieta and Kelner, Sabrina Gozlan and Coller, Beth-Ann G and Boulos, Fernanda Castro and Nogueira, Mauricio L},
title = {Live, Attenuated, Tetravalent Butantan–Dengue Vaccine in Children and Adults},
journal = {New England Journal of Medicine},
year = {2024},
volume = {390},
number = {5},
pages = {397--408},
doi = {10.1056/nejmoa2301790}
}
EUVIMED